Heart failure (chronical)

Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
[15955798] QJM 98(7): 493-7 (2005)

Heart failure in older people: causes, diagnosis and treatment.
[11850305] Age Ageing 31(1): 29-36 (2002)

Beta-blockers in left ventricular systolic dysfunction--from evidence to practice.
[11850304] Age Ageing 31(1): 23-8 (2002)

Beta-blockers: the new standard of therapy for mild heart failure.
[10809026] Arch Intern Med 160(9): 1237-47 (2000)

Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.
[10724047] Arch Intern Med 160(5): 621-7 (2000)

Newer drug therapy for congestive heart failure.
[10371225] Arch Intern Med 159(11): 1177-83 (1999)

Sympathetic activation in heart failure and its treatment with beta-blockade.
[9989534] Arch Intern Med 159(3): 225-34 (1999)

A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
[19841485] Neth J Med 67(9): 284-94 (2009)

New developments in the management of heart failure: a review of the literature in 2002.
[12918546] Neth J Med 61(5 Suppl): 19-27 (2003)

Aldosterone receptor antagonists for heart failure: current status, future indications.
[16548448] Cleve Clin J Med 73(3): 257-60, 264-8 (2006)

Carvedilol in the treatment of elderly patients with chronic heart failure.
[18488879] Clin Interv Aging 3(1): 55-70 (2008)

Management of end stage heart failure.
[17435073] Heart 93(5): 626-31 (2007)

Surgery for heart failure.
[17322524] Heart 93(3): 392-402 (2007)

Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients.
[16339814] Heart 92(12): 1728-31 (2006)

Origin of symptoms in chronic heart failure.
[16159969] Heart 92(1): 12-6 (2006)

Systematic review of multidisciplinary interventions in heart failure.
[15958358] Heart 91(7): 899-906 (2005)

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
[15894755] Heart 91(6): 707-9 (2005)

Heart failure: aetiology, diagnosis, and treatment.
[12433879] Heart 88(6): 567-9 (2002)

Heart failure in the young.
[12117860] Heart 88(2): 198-202 (2002)

Heart failure: What causes the symptoms of heart failure?
[11602559] Heart 86(5): 574-8 (2001)

Epidemiology, aetiology, and prognosis of heart failure.
[10768918] Heart 83(5): 596-602 (2000)

Major beta blocker mortality trials in chronic heart failure: a critical review.
[10574906] Heart 82 Suppl 4(-): IV14-22 (1999)

Angiotensin II receptor antagonists for heart failure.
[9764049] Heart 80(1): 5-6 (1998)

The origin of symptoms in chronic heart failure.
[9414998] Heart 78(5): 429-30 (1997)

Inhibitors of the renin-angiotensin system in established cardiac failure.
[8977368] Heart 76(3 Suppl 3): 83-91 (1996)

How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
[7946810] Br Heart J 72(3 Suppl): S81-6 (1994)

Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
[7946809] Br Heart J 72(3 Suppl): S75-80 (1994)

Results of clinical trials with diuretics in heart failure.
[7946764] Br Heart J 72(2 Suppl): S68-72 (1994)

Physiological rationale for co-treatment with diuretics in heart failure.
[7946763] Br Heart J 72(2 Suppl): S63-7 (1994)

Diuretic induced changes in symptoms and quality of life.
[7946762] Br Heart J 72(2 Suppl): S57-62 (1994)

Electrophysiological impact of diuretics in heart failure.
[7946761] Br Heart J 72(2 Suppl): S54-6 (1994)

Neuroendocrine effects of diuretics in heart failure.
[7946760] Br Heart J 72(2 Suppl): S51-3 (1994)

Vascular effects of diuretics in heart failure.
[7946759] Br Heart J 72(2 Suppl): S48-50 (1994)

Haemodynamic effects of diuretics in heart failure.
[7946758] Br Heart J 72(2 Suppl): S44-7 (1994)

Neuroendocrine excitation in heart failure.
[7946753] Br Heart J 72(2 Suppl): S28-30 (1994)

Peripheral circulatory adaptations to pump failure of the heart.
[7946752] Br Heart J 72(2 Suppl): S22-7 (1994)

Central haemodynamic expressions of heart failure.
[7946751] Br Heart J 72(2 Suppl): S18-21 (1994)

Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.
[7946750] Br Heart J 72(2 Suppl): S10-7 (1994)

Beta blockers and the failing heart: is it time for a U-turn?
[7913613] Br Heart J 70(1): 8-12 (1993)

Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?
[8489856] Br Heart J 69(4): 282-3 (1993)

Vascular tone in heart failure: the neuroendocrine-therapeutic interface.
[1747275] Br Heart J 66(4): 264-7 (1991)

Congestive cardiac failure: central role of the arterial blood pressure.
[3311096] Br Heart J 58(3): 190-203 (1987)

Drug treatment of heart failure.
[3899148] Br Heart J 54(3): 234-42 (1985)

Heart failure as a multiple hormonal deficiency syndrome.
[19808331] Circ Heart Fail 2(2): 151-6 (2009)

Immunological mechanisms of pentoxifylline in chronic heart failure.
[19168508] Eur J Heart Fail 11(2): 113-8 (2009)

Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.
[9738164] Can J Cardiol 14(8): 1045-53 (1998)

Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.
[19689618] Cardiovasc Ther 27(3): 187-93 (2009)

Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.
[19356479] JACC Cardiovasc Imaging 1(4): 536-55 (2008)

Nebivolol in the treatment of chronic heart failure.
[18078016] Vasc Health Risk Manag 3(5): 647-54 (2007)

A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus.
[18078015] Vasc Health Risk Manag 3(5): 639-45 (2007)

Aldosterone antagonism in heart failure.
[18078011] Vasc Health Risk Manag 3(5): 605-9 (2007)

Bisoprolol in the treatment of chronic heart failure.
[17969374] Vasc Health Risk Manag 3(4): 431-9 (2007)

Sarcomeric dysfunction in heart failure.
[18055579] Cardiovasc Res 77(4): 649-58 (2008)

Statins in the treatment of chronic heart failure: biological and clinical considerations.
[16730683] Cardiovasc Res 71(3): 443-54 (2006)

Something old, something new: changing views on the cellular mechanisms of heart failure.
[16202399] Cardiovasc Res 68(2): 167-74 (2005)

Electrophysiological changes in heart failure and their relationship to arrhythmogenesis.
[14736537] Cardiovasc Res 61(2): 208-17 (2004)

Do we understand why regression of left ventricular hypertrophy is beneficial?
[14659790] Cardiovasc Res 60(3): 463-4 (2003)

Relevance of Na+-Ca2+ exchange in heart failure.
[12650870] Cardiovasc Res 57(4): 921-33 (2003)

The Na, K-ATPase in the failing human heart.
[12650869] Cardiovasc Res 57(4): 913-20 (2003)

[Na+]i handling in the failing human heart.
[12650866] Cardiovasc Res 57(4): 874-86 (2003)

Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis.
[12031697] Cardiovasc Res 54(3): 516-27 (2002)

Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
[11476740] Cardiovasc Res 51(3): 495-509 (2001)

Mitochondrial pathology in cardiac failure.
[11121792] Cardiovasc Res 49(1): 17-26 (2001)

Electrophysiological remodeling in hypertrophy and heart failure.
[10533566] Cardiovasc Res 42(2): 270-83 (1999)

Beta-adrenoceptor blockers in chronic heart failure--a review.
[9278193] Br J Clin Pharmacol 44(2): 111-8 (1997)

Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.
[2547407] Br J Clin Pharmacol 27(5): 527-37 (1989)

Regulation of beta-adrenoceptor signaling in cardiac function and disease.
[10471415] Pharmacol Rev 51(3): 465-501 (1999)

The adrenergic pathway and heart failure.
[14749495] Recent Prog Horm Res 59(-): 13-30 (2004)

Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications.
[17067363] J Thromb Haemost 5(2): 224-31 (2007)

Congestive heart failure.
[3281740] CMAJ 138(8): 689-94 (1988)

Beta blockers for congestive heart failure.
[17297209] Acta Med Indones 39(1): 44-8 (2007)

The failing ventricle: what initiates the complex ventricular arrhythmias?
[19666836] Am J Physiol Heart Circ Physiol 297(4): H1198-9 (2009)

Cardiac GPCRs: GPCR signaling in healthy and failing hearts.
[17376402] Biochim Biophys Acta 1768(4): 1006-18 (2007)

The role of vasopressin in congestive heart failure.
[16970149] Cleve Clin J Med 73 Suppl 3(-): S19-23 (2006)

Biofeedback in the treatment of heart failure.
[20622078] Cleve Clin J Med 77 Suppl 3(-): S56-9 (2010)

Electrical vagus nerve stimulation for the treatment of chronic heart failure.
[21972326] Cleve Clin J Med 78 Suppl 1(-): S24-9 (2011)

Sodium and water retention in heart failure and diuretic therapy: basic mechanisms.
[16786906] Cleve Clin J Med 73 Suppl 2(-): S2-7; discussion S30-3 (2006)

Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?
[21576513] Mayo Clin Proc 86(6): 531-9 (2011)

Chronic heart failure: contemporary diagnosis and management.
[20118395] Mayo Clin Proc 85(2): 180-95 (2010)

Beta-blocker use for the stages of heart failure.
[19648389] Mayo Clin Proc 84(8): 718-29 (2009)

Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.
[17289931] Physiology (Bethesda) 22(-): 56-64 (2007)

A leakage leads to failure: roles of sarcoplasmic reticulum Ca2+ leak via RyR2 in heart failure progression.
[20157050] Hypertension 55(4): 849-51 (2010)

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
[19324966] Circulation 119(14): e391-479 (2009)

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
[19324967] Circulation 119(14): 1977-2016 (2009)

The heart failure spectrum: time for a phenotype-oriented approach.
[19506105] Circulation 119(24): 3044-6 (2009)

Cardiac-troponin-guided heart failure management: is it possible in clinical practice?
[21289461] Circ J 75(3): 542-3 (2011)

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
[18799522] Eur Heart J 29(19): 2388-442 (2008)

Pathophysiology of chronic heart failure.
[19634500] Rev Port Cardiol 28(4): 439-71 (2009)

Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction.
[18751512] Rev Port Cardiol 27(6): 851-6 (2008)

Cardiac adrenoceptors: physiological and pathophysiological relevance.
[16612046] J Pharmacol Sci 100(5): 323-37 (2006)

Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy.
[18682409] Europace 10(9): 1029-33 (2008)

New therapeutic targets for the development of positive inotropic agents.
[22127109] Discov Med 12(66): 381-92 (2011)

Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.
[15146232] J Clin Invest 113(10): 1379-82 (2004)

Heart failure management: the present and the future.
[19203220] Antioxid Redox Signal 11(8): 1989-2010 (2009)

Gene and cell therapy for heart failure.
[19416058] Antioxid Redox Signal 11(8): 2025-42 (2009)

The challenge of comprehensive disease management in heart failure.
[21910375] Isr Med Assoc J 13(8): 494-5 (2011)

Immunological mediated therapies for heart failure.
[19637509] Isr Med Assoc J 11(5): 301-5 (2009)

Use of aldosterone antagonists in heart failure.
[19843900] JAMA 302(15): 1658-65 (2009)

Heart failure with normal ejection fraction (HFNEF): is it worth considering?
[20033859] Swiss Med Wkly 140(5-6): 66-72 (2010)

Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.
[20539841] Vasc Health Risk Manag 6(-): 387-97 (2010)

The causes, consequences, and treatment of left or right heart failure.
[21603593] Vasc Health Risk Manag 7(-): 237-54 (2011)

Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
[17583173] Vasc Health Risk Manag 3(1): 31-7 (2007)

Heart failure with preserved ejection fraction: fighting misconceptions for a new approach.
[21789346] Arq Bras Cardiol 96(6): 504-14 (2011)

Treatment of heart failure with normal ejection fraction.
[20730271] Arq Bras Cardiol 94(3): 391-402, 414-26 (2010)

Heart failure with normal ejection fraction.
[20549032] Arq Bras Cardiol 94(5): 652-60, 694-702 (2010)

Behavior of central and peripheral chemoreflexes in heart failure.
[21448511] Arq Bras Cardiol 96(2): 161-7 (2011)

I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure.
[16211166] Arq Bras Cardiol 85 Suppl 3(-): 49-94; 1-48 (2005)

Drug therapy of cardiac diseases in children.
[19383992] Indian Pediatr 46(4): 310-38 (2009)

Carotid body function in heart failure.
[17374517] Respir Physiol Neurobiol 157(1): 171-85 (2007)

Low pulse pressure as a predictor of death in patients with mild to advanced heart failure.
[20548803] Tex Heart Inst J 37(3): 284-90 (2010)

Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment.
[20010468] Pol Arch Med Wewn 119(12): 815-9 (2009)

Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
[15030275] Expert Rev Cardiovasc Ther 1(2): 157-60 (2003)

Electrophysiological remodeling in heart failure.
[20096285] J Mol Cell Cardiol 48(4): 619-32 (2010)

Extracellular matrix remodeling during the progression of volume overload-induced heart failure.
[19524591] J Mol Cell Cardiol 48(3): 564-9 (2010)

Cardiac sympathetic nerve terminal function in congestive heart failure.
[17588326] Acta Pharmacol Sin 28(7): 921-7 (2007)

Heart failure in subjects with chronic kidney disease: Best management practices.
[21160712] World J Cardiol 2(5): 112-7 (2010)

Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man.
[21686225] Trans Am Clin Climatol Assoc 122(-): 198-214 (2011)

Changing beta-blockers in heart failure: when is a class not a class?
[18505613] Br J Gen Pract 58(551): 387-9 (2008)

Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure.
[15830034] Timely Top Med Cardiovasc Dis 9(-): E9 (2005)

The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.
[18081719] Eur J Haematol 80(2): 93-106 (2008)

You can do more to slow the progression of heart failure.
[19284937] J Fam Pract 58(3): 122-8 (2009)

Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
[20538132] Am J Cardiol 105(12):1794-7 (2010)

TOPCAT misses its primary endpoint: Should spironolactone be abandoned in HFpEF?
[24749108] Glob Cardiol Sci Pract 2013(4):357-60 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart failure (chronical).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart failure (chronical).php on line 92